Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II. (Q40599458)

21 September 2017

title

Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II. (English)

1 reference

21 September 2017

main subject

Plasmodium falciparum

0 references

malaria

0 references

author name string

Wilai Noonpakdee

1

1 reference

21 September 2017

Jinrapa Pothikasikorn

2

1 reference

21 September 2017

Wirat Nimitsantiwong

3

1 reference

21 September 2017

Prapon Wilairat

4

1 reference

21 September 2017

publication date

1 March 2003

1 reference

Biochemical and Biophysical Research Communications

21 September 2017

published in

1 reference

21 September 2017

volume

302

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

659-664

1 reference

Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Malaria, the submerged disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

7 January 2021

The treatment of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Current concepts in antisense drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligodeoxynucleotides as clinical therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense-oligonucleotide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Does antisense make sense?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure and mechanism of DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure of DNA topoisomerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

DNA topoisomerase poisons as antitumor drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

The gene encoding topoisomerase II from Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Human malaria parasites in continuous culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Non-sequence-specific antimalarial activity of oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Anti-sense oligodeoxynucleoside phosphorothioates nonspecifically inhibit invasion of red blood cells by malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Blocking of the receptor-mediated invasion of erythrocytes by Plasmodium knowlesi malaria with sulfated polysaccharides and glycosaminoglycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Malaria merozoite surface protein antisense oligodeoxynucleotides lack antisense activity but function as polyanions to inhibit red cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Intraerythrocytic expression of topoisomerase II from Plasmodium falciparum is developmentally regulated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Antisense oligonucleotides: towards clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

Direct access to serum macromolecules by intraerythrocytic malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900246-8

10.1016/S0006-291X(03)00246-8

7 January 2021

Identifiers

DOI

1 reference

release_6znrsdoj2bbs5kqijuk3ynhfty

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6znrsdoj2bbs5kqijuk3ynhfty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference